Physician profile
Stephen Eric Presser
NPI 1144302027
$2,537.77
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,982 · 2020: $533 · 2022: $23.16.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $859.59 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $267.19 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $235.88 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $229.41 | 2019 | |
| Janssen Biotech, INC. | $221.16 | 2019-2020 | |
| Pfizer INC. | $177.09 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $97.56 | 2019 | |
| Lilly USA, LLC | $93.06 | 2019 | |
| Amgen INC. | $86.10 | 2019 | |
| Ucb, INC. | $85.87 | 2019 | |
| Celgene Corporation | $65.04 | 2019 | |
| Genentech USA, INC. | $32.96 | 2019 | |
| Vyne Pharmaceuticals INC. | $26.93 | 2020 | |
| Almirall LLC | $24.25 | 2020 | |
| Smith+Nephew, INC. | $12.80 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $11.49 | 2019 | |
| Merck Sharp & Dohme LLC | $11.39 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Presser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.